Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial - Concepedia

Concepedia

Publication | Closed Access

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial

482

Citations

31

References

2012

Year

Eric Van Cutsem, Sanne de Haas, Yoon‐Koo Kang, Atsushi Ohtsu, Niall C. Tebbutt, Jianming Xu, Wei Peng Yong, Bernd Langer, Paul Delmar, Stefan Scherer,

Journal of Clinical Oncology

Abstract

Plasma VEGF-A and tumor neuropilin-1 are strong biomarker candidates for predicting clinical outcome in patients with advanced gastric cancer treated with bevacizumab.

References

	Year	Citations

Page 1